RIYADH, Saudi Arabia, Nov. 13, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSHRC) will host the Minimally Invasive Organ Transplant Consensus Conference (MIOT.CC) from December 12 to 14, 2024, at the InterContinental Hotel in Riyadh. Global experts and medical professionals will gather to explore advancements in minimally invasive transplant techniques, focusing on laparoscopic and robotic procedures that improve surgical precision and patient outcomes.
Under the leadership of Prof. Dieter Broering, Executive Director of the Organ Transplant Center of Excellence, KFSHRC has set new standards in liver transplant through pioneering robotic surgery. Having performed the world’s first fully robotic living donor liver transplant, KFSHRC established a global benchmark for surgical innovation and safety. In 2024, it furthered this legacy with the world’s first fully robotic heart transplant. With nearly 9,000 successful transplants since 1981, including a record 1,092 in 2023, KFSHRC continues innovation in transplant procedures.
KFSHRC invites medical professionals, surgeons, and healthcare leaders to attend MIOT.CC, and engage in groundbreaking discussions with pioneering robotic transplant experts, shaping the future of transplant surgery.
Join leading experts in shaping the future of robotic and minimally invasive surgery by registering today at: MIOT.cc
It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world’s best 250 hospitals and included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/eff1b024-dcee-4693-b4c1-6c64c076451d
https://www.globenewswire.com/NewsRoom/AttachmentNg/ada0466e-9180-48af-9b08-e2938eb2abed
GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey’s…
AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships…
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…
Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…
Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…
King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="600px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="399px" width="600px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="1px" width="1px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
